Medra
Medra builds an AI-powered robotic platform for autonomous laboratory work in the life sciences. Its "Physical AI Scientist" combines robotic hardware, computer vision, and scientific reasoning AI to design, execute, and continuously optimize experiments — gene editing, RNA/nucleic-acid work, antibody design, and cell-based assays — the way a human scientist would. Units are deployed at partner sites including Genentech and Addition Therapeutics, with a DARPA collaboration on its AI Experimentalist reasoning layer. Founded by Michelle Lee and headquartered in San Francisco, Medra raised a $52M Series A (Dec 2025) from investors including Lux Capital and Menlo Ventures. As of this enrichment pass Medra publishes no public API, SDK, developer portal, or documentation surface.
Medra is profiled on the APIs.io network. Tagged areas include Company, Robotics, Artificial Intelligence, Life Sciences, and Drug Discovery.
Medra’s developer surface includes engineering blog and 2 more developer resources.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Access & Security 1
Authentication, authorization, and security posture
Company 2
The organization behind the API